Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 1
2004 6
2005 6
2006 8
2007 12
2008 8
2009 8
2010 6
2011 12
2012 11
2013 15
2014 7
2015 11
2016 9
2017 14
2018 6
2019 15
2020 15
2021 22
2022 25
2023 12
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Results by year

Filters applied: . Clear all
Page 1
YTHDF2-mediated regulations bifurcate BHPF-induced programmed cell deaths.
Lin J, Zhan G, Liu J, Maimaitiyiming Y, Deng Z, Li B, Su K, Chen J, Sun S, Zheng W, Yu X, He F, Cheng X, Wang L, Shen B, Yao Z, Yang X, Zhang J, He W, Wu H, Naranmandura H, Chang KJ, Min J, Ma J, Björklund M, Xu PF, Wang F, Hsu CH. Lin J, et al. Among authors: hsu ch. Natl Sci Rev. 2023 Aug 28;10(12):nwad227. doi: 10.1093/nsr/nwad227. eCollection 2023 Dec. Natl Sci Rev. 2023. PMID: 38152479 Free PMC article.
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Clinical Trial.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klümpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Mitchell EP, Komatsu Y, Masuda K, Ahn D, Epstein RS, Halim AB, Fu Y, Salimi T, Wacheck V, He Y, Liu M, Benhadji KA, Bridgewater JA; FOENIX-CCA2 Study Investigators. Goyal L, et al. N Engl J Med. 2023 Jan 19;388(3):228-239. doi: 10.1056/NEJMoa2206834. N Engl J Med. 2023. PMID: 36652354 Clinical Trial.
Defining conversion therapy for esophageal squamous cell carcinoma.
Matsuda S, Tsushima T, Kato K, Hsu CH, Lee JM, Wong IY, Wang HC, Kang CH, Guo X, Yamamoto S, Tsuji T, Kawakubo H, Takeuchi H, Law S, Kitagawa Y. Matsuda S, et al. Among authors: hsu ch. Ann Gastroenterol Surg. 2022 Oct 19;7(1):7-9. doi: 10.1002/ags3.12623. eCollection 2023 Jan. Ann Gastroenterol Surg. 2022. PMID: 36643357 Free PMC article.
211 results